Search

Your search keyword '"Bassez, G."' showing total 275 results

Search Constraints

Start Over You searched for: Author "Bassez, G." Remove constraint Author: "Bassez, G."
275 results on '"Bassez, G."'

Search Results

4. VP429 Impaired skeletal muscle strength in adult patients with laminopathies

11. Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood

12. Development and validation of a motor function classification in patients with neuromuscular disease: The NM-Score

14. REGISTRIES AND CARE OF NMD

15. Improved cardiac outcomes by early treatment with angiotensin-converting enzyme inhibitors in becker muscular dystrophy

17. Late-onset cervicoscapular muscle atrophy and weakness after radiotherapy for Hodgkin disease: a case series

20. Long-term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: prospective analysis from the French Pompe Registry

21. 222nd ENMC International Workshop: Myotonic dystrophy, developing a European consortium for care and therapy, Naarden, The Netherlands, 1-2 July 2016

22. AUTOIMMUNE MYOPATHIES

23. FSHD / OPMD / MYOTONIC DYSTROPHY

24. FSHD / OPMD / MYOTONIC DYSTROPHY

25. DMD – BIOMARKERS & OUTCOME MEASURES

28. P.335Phenotypic and genomic characterization as predictors of DMD 45 to 55 multi-exon skipping therapy

29. Eye Symptoms and Ophthalmologic Care in a Myotonic Dystrophy Type 1 (DM1)

30. Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease (vol 13, 155, 2018)

35. CONGENITAL MYASTHENIC SYNDROMES AND MYASTHENIA

36. FSHD / OPMD / EDMD / DMI

38. Incidence and predictors of venous thromboembolism in inherited myopathies: A higher risk in myotonic dystrophy

39. Survival in myotonic dystrophy type 1 predicted by the new DM1 survival risk score

42. Association between mutation size and cardiac involvement in myotonic dystrophy type 1: an analysis of the DM1-heart registry

45. Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients

46. Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease

48. Association between mutation size and cardiac involvement in myotonic dystrophy type 1: when size matters

Catalog

Books, media, physical & digital resources